Page 7 - Genome Sequence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Reinfection in those folks. so it's not completely protective. is it partially protective? i can't tell you yet until we have more data. >> now another form of treatment, right, for those already infected with this are anti viral drugs, pfizer has asked, it's applied for emergency use authorization for its anti viral drug. you have said there's reason to be optimistic that an anti viral drug like that for people who get infected with omicron might help keep them out of the hospital or getting severe illness. tell us why you have that reason for optimism. >> well again, the data that pfizer gen...

Those slow steps in vaccine development not be so slow, but without compromising the rigor of the analysis of the trials. part of it also was assisted by the new technology of mrna which made it possible to design a vaccine within hours after learning about the virus's genome sequence and to get the first dose in the phase 1 trial participants in the first 60 days which is amazing. everything had to be done in the most strictest careful way. the trials for pfizer and moderna and j&j involving at least 30,000 participants in the trials with rigorous assessment of their response, and proving 95 ...

Seedrachen sind ein bemerkenswertes Beispiel der Evolution. Nun haben Forscher ergründet, wie sich die genetische Basis der Tiere auf ihr ungewöhnliches Erscheinungsbild auswirkt – und wie in den Genen überhaupt die Geschlechter der Tiere abzulesen sind. Klassische X- und Y-Chromosomen fehlen ihnen nämlich.

Yes, it is happening. remember zeinab, about ten years ago, africa did not have the ability to sequence the genomes. in 2020, we did ourfirst genome sequence, and very quickly, which means things are changing. we do have now a new initiative across africa called the tridome genome, african genome. and we believe that with resources, with colleagues, we can effectively perform both sequences and actually provide the necessary information for gene therapies and then to provide the necessary information that are needed to develop the right type of vaccines for infectious diseases. we have now the...

Only 2% of sequenced human genome is african. most of it's focused on, you know, caucasian genome. you're saying that we could learn a lot more about how to survive infectious diseases from the diversity in africa, and it could lead to gene—based therapies to help us treat cancer and alzheimer's and many other diseases. why has africa been left out, then, of this kind of scientific research? and can your centre, the excellence centre for genomic diseases in africa, help to close the gap? thank you. yes, it is happening. i remember saying about ten years ago, africa did not have the ability t...